10 Stocks to Buy According to Stephen DuBois' Camber Capital Management
In this article, we discuss 10 Stocks to Buy According to Stephen DuBois' Camber Capital Management.
Ionis Pharmaceuticals Inc (IONS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 4,701,297 | $171,691 | -24% | 1.01% |
| 2. | Camber Capital Management Stephen Dubois | 2,700,000 | $99,954 | -10% | 4.33% |
| 3. | 78,898,000 | $69,839 | -2% | 2.78% | |
| 4. | 42,313,000 | $37,738 | -1% | 3.62% | |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 705,811 | $26,129 | +16% | 0.07% |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $45.20 | 1 | Officer | 20,352 | 2022-08-05 | Filing | |
| $38.78 | 644 | Director | 18,791 | 2022-07-15 | Filing | |
| $37.74 | 689 | Director | 19,435 | 2022-07-15 | Filing | |
| $44.15 | 378 | Officer | 20,353 | 2022-04-21 | Filing | |
| $40.06 | 6,792 | Officer | 34,536 | 2022-04-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 205,789 | $7,618,308 | 0% | |
| 2. | 194,492 | $7,200,094 | 0.1% | |
| 3. | 119,970 | $4,441,289 | 0% | |
| 4. | 61,497 | $2,277,000 | 0.03% | |
| 5. | 39,110 | $1,447,852 | 0.01% |
News See All
Should I Buy Ionis Pharmaceuticals, Inc. (IONS)?
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the fourth ...
Cathie Wood’s ARK Portfolio: Top 15 Losers
In this article, we discuss the 15 biggest losers in the portfolio of Cathie Wood's ARK.
Hedge Funds Are Betting On Ionis Pharmaceuticals, Inc. (IONS)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Are Selling Ionis Pharmaceuticals, Inc. (IONS)
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...
10 Best Pharmaceutical Stocks to Buy According to Cathie Wood
In this article we discuss the 10 best pharmaceutical stocks to buy according to Cathie Wood.
Hedge Funds Dipping Their Toes Into Ionis Pharmaceuticals, Inc. (IONS)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Did Hedge Funds Make The Right Call On Ionis Pharmaceuticals, Inc. (IONS) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Hedge Funds Aren't Crazy About Ionis Pharmaceuticals, Inc. (IONS) Anymore
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
Hedge Funds Aren't Done Buying Ionis Pharmaceuticals, Inc. (IONS)
We hate to say this but, we told you so.
Billionaire Hedge Funds
